Related Experiment Video
Updated: Jun 4, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
From Crisis to Complications: A Nationwide Cohort Study Assessing One-Year Cardiovascular and Thromboembolic Risks
Andreas Liliequist1,2, Per Svensson3, Robin Hofmann3
1Department of Medicine, Solna, Karolinska Institutet, 171 64 Stockholm, Sweden.
Insights
Patients with severe COVID-19 requiring intensive care face a significantly higher risk of cardiovascular and thrombotic events, including atherosclerotic cardiovascular disease (ASCVD) and venous thromboembolism, within one year post-discharge.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Long-term risks of cardiovascular and thrombotic events post-severe COVID-19 are not well-established.
- Severe COVID-19 necessitates intensive care, often involving mechanical ventilation.
- Understanding post-discharge risks is crucial for patient management and public health strategies.
Purpose of the Study:
- To evaluate the one-year risk of atherosclerotic cardiovascular disease (ASCVD) after hospital discharge in severe COVID-19 survivors.
- To assess secondary outcomes including myocardial infarction, stroke, all-cause mortality, and venous thromboembolic events.
- To quantify the association between severe COVID-19 and post-discharge cardiovascular and thrombotic risks.
Main Methods:
- Nationwide, register-based case-control study design.
- Inclusion of severe COVID-19 patients requiring mechanical ventilation, matched with population controls.
- Primary outcome: ASCVD (composite of myocardial infarction, unstable angina, ischemic stroke); Secondary outcomes: MI, stroke, mortality, VTE.
Main Results:
- A total of 31,375 individuals (2,854 severe COVID-19 cases, 26,885 controls) were analyzed.
- Adjusted Hazard Ratio (HR) for ASCVD within one year was 3.1 (95% CI 1.7-5.4).
- Significantly elevated HRs for pulmonary embolism (49.4) and deep venous thrombosis (16.0) were observed.
Conclusions:
- Severe COVID-19 requiring intensive care is linked to a substantially increased one-year risk of ASCVD.
- A significant rise in venous thromboembolic events (VTE) was noted in severe COVID-19 survivors.
- Findings highlight the need for vigilant cardiovascular monitoring in patients recovering from critical COVID-19.
Abstract:
Background: The long-term risk of cardiovascular and thrombotic events following severe COVID-19 remains largely unknown. This study aimed to assess the risk of atherosclerotic cardiovascular disease (ASCVD) within one year after hospital discharge in patients who received intensive care for severe COVID-19. Methods: A register-based nationwide case-control study on a cohort of patients with severe COVID-19 (cases) requiring mechanical ventilation and discharged alive without experiencing cardiovascular or thrombotic events during their hospital stay. Each case was matched (age, sex, district of residence) with up to 10 population-based controls. The primary outcome was ASCVD occurring after hospital discharge, defined as a composite endpoint, including myocardial infarction (MI), unstable angina pectoris and ischemic stroke. Secondary endpoints were MI, stroke, all-cause mortality, and venous thromboembolic events. Hazard ratio (HR) (95% CI) was used with adjustments for age, sex, socioeconomic factors, and co-morbidities. Results: In total, 31,375 individuals (70% men, median age 62 years) were included, of which 2854 had severe COVID-19 and 26,885 matched control subjects. The adjusted HR for ASCVD during the first year compared to control subjects was 3.1 (95% CI 1.7-5.4). Adjusted HRs for secondary outcomes for myocardial infarction were 2.0 (95% CI 0.8-5.3), for stroke 1.9 (95% CI 0.7-5.3), for pulmonary embolism 49.4 (95% CI 28.0-87.1), and deep venous thrombosis (DVT) 16.0 (95% CI 7.8-32.6). Conclusions: Severe COVID-19 requiring intensive care was associated with a substantial increase in 1-year risk for ASCVD and venous thromboembolic events.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...